论文部分内容阅读
目的观察葛根素注射液对冠心病患者治疗作用及由此而引起的对血粘度及同型半胱氨酸影响。方法 78例确诊为冠心病患者分为治疗组及对照组,经血液检查对比葛根素治疗组血粘度及同型半胱氨酸变化。结果治疗组血粘度及同型半胱氨酸均较前下降,P<0.05,有统计学意义。讨论葛根素注射液在冠心病的治疗中有较好的临床疗效,可降低影响斑块形成的血粘度及同型半胱氨酸,值得临床应用。
Objective To observe the therapeutic effect of puerarin injection on patients with coronary heart disease and its effect on blood viscosity and homocysteine. Methods A total of 78 patients diagnosed as CHD were divided into treatment group and control group. The changes of blood viscosity and homocysteine in puerarin-treated group were compared by blood test. Results The blood viscosity and homocysteine in the treatment group were significantly lower than before (P <0.05), with statistical significance. Discussion puerarin injection in the treatment of coronary heart disease have better clinical efficacy, can reduce the formation of plaque blood viscosity and homocysteine, is worth clinical application.